Leclercq, V.; Van den Houte, N.; Gisle, L.; Roukaerts, I.; Barbezange, C.; Desombere, I.; Duysburgh, E.; Van der Heyden, J.
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study. Viruses 2022, 14, 920.
https://doi.org/10.3390/v14050920
AMA Style
Leclercq V, Van den Houte N, Gisle L, Roukaerts I, Barbezange C, Desombere I, Duysburgh E, Van der Heyden J.
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study. Viruses. 2022; 14(5):920.
https://doi.org/10.3390/v14050920
Chicago/Turabian Style
Leclercq, Victoria, Nayema Van den Houte, Lydia Gisle, Inge Roukaerts, Cyril Barbezange, Isabelle Desombere, Els Duysburgh, and Johan Van der Heyden.
2022. "Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study" Viruses 14, no. 5: 920.
https://doi.org/10.3390/v14050920
APA Style
Leclercq, V., Van den Houte, N., Gisle, L., Roukaerts, I., Barbezange, C., Desombere, I., Duysburgh, E., & Van der Heyden, J.
(2022). Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study. Viruses, 14(5), 920.
https://doi.org/10.3390/v14050920
